Oncology Letters

Papers
(The H4-Index of Oncology Letters is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Prognostic value of circWWC3 as a novel survival‑related biomarker for clear cell renal cell carcinoma71
Synchronous primary colorectal mucinous adenocarcinoma and pancreatic ductal adenocarcinoma: A case report49
Correlations between serum lipid and Ki‑67 levels in different breast cancer molecular subcategories48
Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi‑institutional study40
Novel predictive nomograms based on aspartate aminotransferase‑to‑platelet ratio index for hepatocellular carcinoma with post‑operative adjuvant transarterial chemoembolization38
FLASH radiotherapy: A promising new method for radiotherapy (Review)36
Immunoexpression of p62/SQSTM1/Sequestosome‑1 in human primary and recurrent IDH1/2 wild‑type glioblastoma: A pilot study35
Evaluation of the therapeutic effects and tolerability of modified lenvatinib administration methods for unresectable hepatocellular carcinoma: A preliminary study32
Upregulated miR‑378a‑3p expression suppresses energy metabolism and promotes apoptosis by targeting a GLUT‑1/ALDOA/PKM2 axis in esophageal carcinoma31
Successful treatment with trastuzumab plus chemotherapy as the first‑line regimen in advanced small bowel adenocarcinoma harboring HER2 amplification: A report of two cases30
Benefits of adjuvant treatment with the Pingxiao capsule in patients with early breast cancer: A single‑center retrospective cohort study30
Laparoscopic hepatopancreatoduodenectomy for synchronous intrahepatic and extrahepatic cholangiocarcinoma: A case report29
[Corrigendum] Molecular heterogeneity of guanine nucleotide binding‑protein γ subunit 4 in left‑ and right‑sided colon cancer28
Cancer marker TNFRSF1A: From single‑cell heterogeneity of renal cell carcinoma to functional validation28
Metanephric adenoma in children: A case report and literature review28
Clinical value of color Doppler ultrasound combined with serum tumor markers for the diagnosis of medullary thyroid carcinoma28
Multiple primary tumors in a patient with non‑small‑cell lung cancer harboring mutations in ERCC6 and LYL1: A case report28
A pilot study on the detection of microsatellite instability using long mononucleotide repeats in solid tumors28
Efficacy and safety of antiangiogenic therapy (bevacizumab or apatinib) plus chemotherapy in patients with platinum‑resistant recurrent ovarian cancer: A retrospective study27
Tissue source may affect the esophageal flora in patients with esophageal squamous cell carcinoma27
Primary osteosarcoma of the kidney: A case report26
Comparative efficacy and safety of first‑line PD‑1/PD‑L1 inhibitors in immunotherapy for non‑small cell lung cancer:  A network meta‑analysis26
All‑trans‑retinoic acid induces RARB‑dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells26
Imaging assessment of tumor densities and sizes following pazopanib treatment for central nervous system solitary fibrous tumors with multiple extracranial metastases: A case series25
Agrin is a novel oncogenic protein in thyroid cancer25
miR‑143‑5p suppresses breast cancer progression by targeting the HIF‑1α‑related GLUT1 pathway25
Metastatic squamous cell carcinoma in the residual spleen diagnosed with emergency ultrasonography: A case report25
Upregulation of long non‑coding RNA LINC00460 in EGFR‑mutant lung cancer indicates a poor prognosis in patients treated with osimertinib25
Primary gingival diffuse large B‑cell lymphoma with muscle invasion: A case report25
0.10128283500671